Submitted by Anonymous (not verified) on 25 February 2026 - 13:56
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 17, Status: Authorised